Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jagsonpal Pharmaceuticals has informed that Meeting of Board of Directors of the Company will be held on Tuesday, the 19th Day of October, 2021, at 12:00 Noon, to consider and approve: The Standalone Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2021, The Limited Review Report on Un-Audited Financial Results of the company for the quarter and half year ended 30th September, 2021, The declaration of Interim Dividend, if any and Any other agenda items as placed before the Board.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1507.00 |
Dr. Reddys Lab | 6037.55 |
Cipla | 1497.30 |
Zydus Lifesciences | 1058.45 |
Lupin | 1630.90 |
View more.. |